Amphetamine-Related Disorders
"Amphetamine-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related or resulting from use of amphetamines.
| Descriptor ID |
D019969
|
| MeSH Number(s) |
C25.775.225 F03.900.225
|
| Concept/Terms |
Amphetamine-Related Disorders- Amphetamine-Related Disorders
- Amphetamine Related Disorders
- Disorder, Amphetamine-Related
- Disorders, Amphetamine-Related
Amphetamine Addiction- Amphetamine Addiction
- Addiction, Amphetamine
- Amphetamine Dependence
- Dependence, Amphetamine
|
Below are MeSH descriptors whose meaning is more general than "Amphetamine-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Amphetamine-Related Disorders".
This graph shows the total number of publications written about "Amphetamine-Related Disorders" by people in this website by year, and whether "Amphetamine-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 4 | 0 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 6 | 0 | 6 |
| 2015 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 5 | 0 | 5 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amphetamine-Related Disorders" by people in Profiles.
-
Cannabis Use Moderates Methamphetamine- and HIV-Related Inflammation: Evidence from Human Plasma Markers. Viruses. 2025 Aug 20; 17(8).
-
A Confirmatory Factor Analysis of the NIH Emotions Toolbox Among People Living with HIV and Who May Use Methamphetamine. AIDS Behav. 2025 Jan; 29(1):55-63.
-
Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension. Chest. 2024 06; 165(6):1518-1533.
-
Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder. J Int Neuropsychol Soc. 2024 01; 30(1):84-93.
-
Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKM? and increased ?OR in the hippocampus of female mice. J Psychopharmacol. 2021 Oct; 35(10):1240-1252.
-
Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV. Harm Reduct J. 2020 06 11; 17(1):41.
-
Assessment of demand for methamphetamine and cigarettes among individuals with methamphetamine use disorder. Exp Clin Psychopharmacol. 2021 Aug; 29(4):334-344.
-
Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use. Drug Alcohol Depend. 2019 12 01; 205:107595.
-
Opioid, cocaine, and amphetamine use disorders are associated with higher30-day inpatient readmission rates in the United States. Subst Abus. 2020; 41(3):365-374.
-
Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance. J Int Neuropsychol Soc. 2019 09; 25(8):787-799.